By Tim O’Brien
What started as a virus quickly became an epidemic and then a global pandemic. The spread of a contagion laid the groundwork for what has become an industry, and it’s now morphing into a religious ideology with all of the familiar trappings.
In just the third quarter of 2021, Pfizer reported its sales rose to $24.1 billion, up 134 percent from a year ago, thanks in large part to its COVID vaccine. The company said it anticipates sales of COVID vaccine to top $36 billion in 2021 and $29 billion in 2022.
For its part, Moderna reports that it anticipates vaccine sales of $17 billion in 2021 and an increase to $22 billion in 2022.
Johnson & Johnson has stated that its COVID vaccine sales will come in around $2.5 billion for 2021.
